Pumas-AI, Inc.
Vijay Ivaturi has a diverse range of work experience in the scientific and pharmaceutical fields. Vijay currently holds the position of Chief Scientific Officer at Pumas-AI, Inc. since July 2019. Vijay is also the President Elect of the International Society of Pharmacometrics, starting in November 2022.
Prior to these roles, Vijay worked as an Assistant Professor at the University of Maryland, Baltimore, starting in February 2013. Before that, they were a Post-Doctoral Fellow at Uppsala Universitet from September 2010 to November 2012.
Vijay earned their PhD from the University of Minnesota, where they studied from January 2007 to August 2010. During their time as a PhD student, they also worked as a CPMS Summer Intern at GlaxoSmithKline in May to August 2009.
Vijay's educational background includes a Masters in Industrial Pharmacy from Saint John's University, which they completed from January 2005 to December 2006. Overall, Vijay's work experience showcases their expertise in scientific research and leadership in the pharmacometrics field.
Vijay Ivaturi obtained their B.Pharm degree from Manipal Academy of Higher Education from the years 2000 to 2004. Following this, they pursued a Masters degree in Pharmaceutics/Drug Delivery at St. John's University for the academic year 2005 to 2006. Vijay then went on to pursue a PhD in Clinical Pharmacology/Pharmacometrics at the University of Minnesota from 2007 to 2010. Lastly, they completed a Post-Doctoral Fellowship in Pharmacometrics at Uppsala University from 2010 to 2012.
This person is not in any teams
This person is not in any offices
Pumas-AI, Inc.
Pumas-AI was founded by Dr. Joga Gobburu and Dr. Vijay Ivaturi, driven by a team of scientists at the University of Maryland in partnership with scientific computing experts. The solutions offered at Pumas-AI are fine-tuned to the needs of healthcare research, regulation and delivery, with a central vision to double pharmaceutical and patient caresuccess by democratizing tools and education in the healthcare data analytics space. With a focused goal on providing better solutions for patient care, be it via pharmaceutical drug development innovation or tools for point of care, Pumas-AI aims to bring value, innovation and efficiency to healthcare.Pumas is a one-stop integrated modeling and simulation platform designed to provide analytic capabilities and support high-performance drug development teams where collaboration is key. Developed for drug/biotech development and therapeutic decision making, it leverages the power of the Julia programming language to combine modern AI with traditional mechanistic models to gain massive computational efficiency. With its complete range of analytics capabilities, Pumas gives pharmaceutical/biotech companies and their investors usable quantitative metrics on technical, regulatory, and commercial success probabilities. Pumas was developed as a cloud-first technology that allows scientists scale to thousands of CPUs and GPUs with a single click. The software is free for non-commercial research and training.